CME Group Inc (CME) Shares Up Despite Recent Market Volatility

The stock price of CME Group Inc (NASDAQ: CME) has jumped by 1.31 compared to previous close of 212.02. Despite this, the company has seen a fall of -0.18% in its stock price over the last five trading days. MarketBeat reported 2024-04-02 that Every cycle brings new opportunities; now that the Federal Reserve (the Fed) is looking to cut interest rates in 2024, the market could be getting ready to shift in a new direction. Banking stocks could be the first to move, as they are tied to the financial pulse of the economy.

Is It Worth Investing in CME Group Inc (NASDAQ: CME) Right Now?

CME Group Inc (NASDAQ: CME) has a price-to-earnings ratio that is above its average at 24.24x. The stock has a 36-month beta value of 0.49. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 0 as “sell.”

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The public float for CME is 358.71M, and at present, short sellers hold a 1.04% of that float. On April 03, 2024, the average trading volume of CME was 1.78M shares.

CME’s Market Performance

CME stock saw a decrease of -0.18% in the past week, with a monthly decline of -2.01% and a quarterly a decrease of 1.99%. The volatility ratio for the week is 1.63%, and the volatility levels for the last 30 days are 1.47% for CME Group Inc (CME). The simple moving average for the last 20 days is -0.75% for CME’s stock, with a simple moving average of 6.06% for the last 200 days.

Analysts’ Opinion of CME

Many brokerage firms have already submitted their reports for CME stocks, with Barclays repeating the rating for CME by listing it as a “Equal Weight.” The predicted price for CME in the upcoming period, according to Barclays is $222 based on the research report published on January 08, 2024 of the current year 2024.

Goldman, on the other hand, stated in their research note that they expect to see CME reach a price target of $195. The rating they have provided for CME stocks is “Sell” according to the report published on January 03rd, 2024.

BofA Securities gave a rating of “Neutral” to CME, setting the target price at $204 in the report published on September 06th of the previous year.

CME Trading at 1.13% from the 50-Day Moving Average

After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.52% of loss for the given period.

Volatility was left at 1.47%, however, over the last 30 days, the volatility rate increased by 1.63%, as shares sank -2.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.31% upper at present.

During the last 5 trading sessions, CME fell by -0.18%, which changed the moving average for the period of 200-days by +18.34% in comparison to the 20-day moving average, which settled at $216.11. In addition, CME Group Inc saw 1.99% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CME starting from SHEPARD WILLIAM R, who purchase 282 shares at the price of $214.71 back on Mar 26 ’24. After this action, SHEPARD WILLIAM R now owns 253,343 shares of CME Group Inc, valued at $60,561 using the latest closing price.

SHEPARD WILLIAM R, the Director of CME Group Inc, purchase 12 shares at $214.71 during a trade that took place back on Mar 26 ’24, which means that SHEPARD WILLIAM R is holding 2,334 shares at $2,670 based on the most recent closing price.

Stock Fundamentals for CME

Current profitability levels for the company are sitting at:

  • 0.62 for the present operating margin
  • 0.84 for the gross margin

The net margin for CME Group Inc stands at 0.58. The total capital return value is set at 0.09. Equity return is now at value 12.05, with 2.12 for asset returns.

Based on CME Group Inc (CME), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at 0.99. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 21.55.

Currently, EBITDA for the company is 3.79 billion with net debt to EBITDA at 0.37. When we switch over and look at the enterprise to sales, we see a ratio of 14.03. The receivables turnover for the company is 4.46for trailing twelve months and the total asset turnover is 0.04.


To sum up, CME Group Inc (CME) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts